Skip to content

A Study on the Relationship between Non-criteria Antiphospholipid Antibodies and Adverse Pregnancy Outcomes

A Study on the Relationship between Non-criteria Antiphospholipid Antibodies and Adverse Pregnancy Outcomes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124078
Enrollment
Unknown
Registered
2026-05-07
Start date
2026-03-07
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse pregnancy outcomes

Interventions

Whether the non criteria antiphospholipid antibodies were positive:none

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Women aged 18-50 years, who are in the preconception period or early pregnancy; 2.Those with a history of adverse pregnancy outcomes or other high-risk factors.

Exclusion criteria

Exclusion criteria: 1. Known presence of other conditions that could lead to miscarriage/placental insufficiency (e.g. chromosomal abnormalities); 2. Currently participating in other interventional clinical trials that may affect the primary outcomes; 3. Those who refuse or are unable to complete follow-up, or whose clinical data are incomplete.

Design outcomes

Primary

MeasureTime frame
Abortion;Term delivery;Premature delivery;

Secondary

MeasureTime frame
Placental abruption;Fetal growth restriction (FGR);Fetal distress or neonatal asphyxia;Preeclampsia;

Countries

China

Contacts

Public ContactRui Zhang

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Zhangrui@mail.sysu.edu.cn+86 137 1146 6910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026